RNU6-1153P

Across TCGA pan-cancer cohorts, RNU6-1153P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RNU6-1153P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RNU6-1153P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU6-1153P expression acts as an unfavorable survival marker, although some lineages such as LUAD and CESC show a favorable association.

LUAD, READ, and MESO are the cancer types where RNU6-1153P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.697	0.340	.001	29	view →
READ	DFS	Tertile	IV	0.240	0.756	<.001	29	view →
MESO	OS	Median	III,IV	0.428	0.641	.004	28	view →
BLCA	OS	Median	III,IV	0.452	0.678	.005	25	view →
PAAD	DFS	Quartile	All	0.167	0.353	.041	12	view →
CESC	DFS	Quartile	All	0.708	0.460	.008	12	view →
ACC	OS	Quartile	All	0.395	0.684	.004	11	view →
OV	OS	Quartile	All	0.428	0.307	.023	8	view →
KIRC	DFS	Tertile	III,IV	0.628	0.325	.024	4	view →
SKCM	DFS	Quartile	IV	0.096	0.869	.038	3	view →
CHOL	OS	Median	IV	1.000	0.286	.024	3	view →
THCA	DFS	Quartile	III,IV	0.422	0.758	.038	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RNU6-1153P–LUAD (OS)

Open the LUAD breakdown →